Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Am J Prev Med. 2014 Apr;46(4):368–377. doi: 10.1016/j.amepre.2013.11.009

Table 3. Secondary outcomes for e-Care participants who completed the follow-up visit, n=90.

Control Web-dietitian

M
(95% CI)
M
(95% CI)
M difference
between
groups
(95% CI)
P-
value

Patients completing follow-up visit 46 44

Change from baseline
HBA1c 0.1 (−0.0, 0.1) −0.0 (−0.1,
0.1)
−0.1 (−0.2,
0.0)
0.11
Fasting blood sugar −1.0 (−3.9,
1.8)
−0.7 (−3.3,
1.9)
0.3 (−3.5, 4.2) 0.86
Total cholesterol −1.8 (−11.4,
7.9)
−5.7 (−13.0,
1.7)
−3.9 (−16.1,
8.2)
0.52
LDL cholesterol −5.2 (−11.6,
1.2)
−7.0 (−14.0,
0.0)
−1.8 (−11.3,
7.7)
0.71
HDL cholesterol −0.3 (−2.8,
2.1)
1.5 (−0.4, 3.5) 1.9 (−1.2, 5.0) 0.24
Fruits and vegetables, number of
servings
0.0 (−0.5, 0.6) 2.3 (1.4, 3.2) 2.3 (1.2, 3.3) <0.01
Hypertension medication classes,
number of classes
0.1 (0.0, 0.4) 0.4 (0.1, 0.7) 0.2 (−0.1, 0.5) 0.16
Hypertension medication adherence
b,c
−0.2 (−0.8,
0.3)
−0.1 (−0.7,
0.5)
0.1 (−0.7, 0.9) 0.79
Satisfaction with hypertension care
(0–10 scale)
−0.5 (−1.1,
0.2)
1.3 (0.4, 2.1) 1.7 (0.7, 2.7) <0.01
Obesity and weight loss quality of
lifea
2.5 (−0.4, 5.3) 5.5 (2.7, 8.3) 3.0 (−1.0, 7.1) 0.14
Patient assessment of chronic illness
care
  Overall score −0.1 (−0.5,
0.2)
2.0 (1.6, 2.3) 2.1 (1.6, 2.6) <0.01
  Patient activation/self-efficacy −0.4 (−0.8,
0.0)
2.1 (1.7, 2.6) 2.5 (1.9, 3.1) <0.01
  Delivery system/practice design −0.3 (−0.7,
0.2)
2.0 (1.5, 2.5) 2.3 (1.6, 2.9) <0.01
  Goal setting/tailoring −0.1 (−0.6,
0.3)
2.1 (1.7, 2.5) 2.3 (1.7, 2.8) <0.01
  Problem solving/contextual −0.3 (−0.6,
0.1)
2.0 (1.6, 2.4) 2.2 (1.7, 2.8) <0.01
  Follow-up/coordination −0.1 (−0.4,
0.2)
1.6 (1.2, 2.0) 1.7 (1.2, 2.2) <0.01

Proportion at follow-up % (95% CI) % (95% CI) RR (95% CI)
Taking any hypertension
medications
52.2 (37.7,
66.6)
63.6 (49.4,
77.9)
1.22 (0.85,
1.74)
0.27
Hypertension medication
intensificationb
41.7 (21.9,
61.4)
55.2 (37.1,
73.3)
1.32 (0.74,
2.36)
0.34
Physical activity, often work up a
sweat
20.5 (8.5,
32.4)
27.9 (14.5,
41.3)
1.36 (0.64,
2.90)
0.42
a

Range=1–10, with higher numbers representing better self-reported quality.

b

Intensification and adherence not defined for patients not taking hypertension medications.

c

Morisky self-reported hypertension medication adherence (range=0–8, with higher scores indicating worse adherence).

HBAlc, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; RR, relative risk